BF Biosciences Limited (PSX:BFBIO)
131.13
-7.73 (-5.57%)
At close: Mar 9, 2026
BF Biosciences Market Cap
BF Biosciences has a market cap or net worth of 11.58 billion as of March 9, 2026. Its market cap has decreased by -33.49% in one year.
Market Cap
11.58B
Enterprise Value
11.32B
Revenue
8.22B
Ranking
n/a
PE Ratio
19.34
Stock Price
131.13
Market Cap Chart
Since October 22, 2024, BF Biosciences's market cap has increased from 7.41B to 11.58B, an increase of 56.37%. That is a compound annual growth rate of 38.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 11.58B | -6.68% |
| Dec 31, 2025 | 12.41B | -40.17% |
| Dec 31, 2024 | 20.75B | 180.05% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samba Bank | 11.79B |
| Century Paper & Board Mills | 12.25B |
| Siemens (Pakistan) Engineering | 12.42B |
| Atlas Insurance | 10.73B |
| Ittehad Chemicals | 12.85B |
| The Thal Industries Corporation | 10.43B |
| Macter International | 12.89B |
| Barkat Frisian Agro | 10.37B |